share_log

Cytokinetics(CYTK.US) Director Sells US$681.67K in Common Stock

moomoo News ·  Apr 25 19:34

$Cytokinetics (CYTK.US)$ Director HENDERSON JOHN T sold 10,562 shares of common stock on Apr 25, 2024 at an average price of $64.54 for a total value of $681.67K.

1714088072459721483.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment